Immunocore Holdings (IMCR) Asset Utilization Ratio (2024 - 2026)

Immunocore Holdings has disclosed Asset Utilization Ratio across 3 years of filings, most recently posting 0.39 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.39, up 17.86% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.39 (up 17.86% YoY), and the FY2025 annual result was 0.39, changed 0.25% from the prior year.
• Asset Utilization Ratio came in at 0.39 for Q1 2026 at Immunocore Holdings, up from 0.37 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.39 in Q1 2026 to a low of 0.28 in Q2 2024.
• The 3-year median for Asset Utilization Ratio is 0.33 (2024), against an average of 0.33.
• Peak annual rise in Asset Utilization Ratio reached 24.46% in 2025, while the deepest fall reached 1.81% in 2025.
• Immunocore Holdings' Asset Utilization Ratio stood at 0.3 in 2024, then rose by 24.46% to 0.37 in 2025, then climbed by 4.67% to 0.39 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.39 (Q1 2026), 0.37 (Q4 2025), and 0.35 (Q3 2025), per Business Quant data.